000 | 01977 a2200565 4500 | ||
---|---|---|---|
005 | 20250515192603.0 | ||
264 | 0 | _c20100323 | |
008 | 201003s 0 0 eng d | ||
022 | _a1029-2403 | ||
024 | 7 |
_a10.3109/10428190903288449 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChebel, Amel | |
245 | 0 | 0 |
_aIndirubin derivatives inhibit malignant lymphoid cell proliferation. _h[electronic resource] |
260 |
_bLeukemia & lymphoma _cDec 2009 |
||
300 |
_a2049-60 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xpharmacology |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aAutophagy _xdrug effects |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aCell Cycle _xdrug effects |
650 | 0 | 4 |
_aCell Cycle Proteins _xmetabolism |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 |
_aCyclin E _xmetabolism |
650 | 0 | 4 |
_aCyclin-Dependent Kinase 6 _xmetabolism |
650 | 0 | 4 |
_aCyclin-Dependent Kinase Inhibitor p21 _xmetabolism |
650 | 0 | 4 | _aCyclin-Dependent Kinase Inhibitor p27 |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIndoles _xpharmacology |
650 | 0 | 4 |
_aIntracellular Signaling Peptides and Proteins _xmetabolism |
650 | 0 | 4 | _aJurkat Cells |
650 | 0 | 4 |
_aLymphocytes _xdrug effects |
650 | 0 | 4 |
_aOximes _xpharmacology |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aKagialis-Girard, Sandrine | |
700 | 1 | _aCatallo, Regine | |
700 | 1 | _aChien, Wei Wen | |
700 | 1 | _aMialou, Valérie | |
700 | 1 | _aDomenech, Carine | |
700 | 1 | _aBadiou, Cedric | |
700 | 1 | _aTigaud, Isabelle | |
700 | 1 | _aFfrench, Martine | |
773 | 0 |
_tLeukemia & lymphoma _gvol. 50 _gno. 12 _gp. 2049-60 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3109/10428190903288449 _zAvailable from publisher's website |
999 |
_c19250378 _d19250378 |